IHC-P analysis of human lung carcinoma tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

IHC-P analysis of human ovary adenocarcinoma tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

IHC-P analysis of human endometrium adenocarcinoma tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

IHC-P analysis of human prostate tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

IHC-P analysis of human colon tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

IHC-P analysis of human pancreas tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

WB analysis of 293T cells transfected with human TDO2 using GTX04090 TDO2 antibody [OTI2A4].
Lane 1 : 293T cells transfected with control vector
Lane 2 : 293T cells transfected with human TDO2
Loading : 5 μg per lane

IHC-P analysis of human tonsil tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

IHC-P analysis of human breast tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min

IHC-P analysis of human liver tissue using TDO2 antibody [OTI2A4].
Antigen retrieval : 10mM citric buffer, pH 6.0, 100ºC for 10min